Is semaglutide a target therapy for acquired hypothalamic obesity?
| Autor: | Prodam F; Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy. flavia.prodam@med.uniupo.it.; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy. flavia.prodam@med.uniupo.it.; Department of Health Sciences, Unit of Endocrinology, University of Piemonte Orientale, Via Solaroli 17, Novara, 28100, Italy. flavia.prodam@med.uniupo.it. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Pituitary [Pituitary] 2024 Oct; Vol. 27 (5), pp. 444-448. Date of Electronic Publication: 2024 Aug 30. |
| DOI: | 10.1007/s11102-024-01443-7 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink